NGF and irritable bowel syndrome: As activation of mast cells in the colonic mucosa of IBS patients induces neuroplastic changes and neuronal sprouting via the release of NGF [11], chemical ingredients in CJAF that inhibit the activation of mast cells could, therefore, exert therapeutic effect on IBS-D.